Akari Therapeutics (AKTX) Depreciation and Depletion (2014 - 2016)
Akari Therapeutics' (AKTX) quarterly Depreciation and Depletion came in at $8594.0 in Q1 2016, up 1024.87% year-on-year from $764.0 in Q2 2015, and up 228.52% quarter-over-quarter from $2616.0 in Q4 2015.
Akari Therapeutics (AKTX) Depreciation and Depletion (2014 - 2016) Analysis & Trends
Akari Therapeutics has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $8594.0 for Q1 2016.
- Depreciation and Depletion for Q1 2016 came in at $8594.0, up 1024.87% year-over-year; the trailing twelve-month figure through Mar 2016 was $14870.0 (up 289.78% YoY), and the FY2020 annual result was $5013.0, down 67.47% from the prior year.
- Depreciation and Depletion came in at $8594.0 for Q1 2016 at Akari Therapeutics, up from $2616.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $8594.0 in Q1 2016 to a low of -$4576.0 in Q3 2015.
- The 3-year median for Depreciation and Depletion is $1596.0 (2014), against an average of $2669.3.
- Across the five-year window, Depreciation and Depletion slumped 414.5% in 2015 and jumped 1024.87% in 2016, its largest moves.
- Akari Therapeutics' Depreciation and Depletion stood at $1596.0 in 2014, then surged by 63.91% to $2616.0 in 2015, then soared by 228.52% to $8594.0 in 2016.
- The last three Depreciation and Depletion figures came in at $8594.0 (Q1 2016), $2616.0 (Q4 2015), and -$4576.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 8,594.00 |
| Mar 31, 2016 | 8,594.00 |
| Dec 31, 2015 | 2,616.00 |
| Dec 31, 2015 | 2,616.00 |
| Sep 30, 2015 | -4,576.00 |
| Sep 30, 2015 | -4,576.00 |
| Jun 30, 2015 | 8,236.00 |
| Jun 30, 2015 | 8,236.00 |
| Mar 31, 2015 | 764.00 |
| Mar 31, 2015 | 764.00 |
| Dec 31, 2014 | 1,596.00 |
| Dec 31, 2014 | 1,596.00 |
| Sep 30, 2014 | 1,455.00 |
| Sep 30, 2014 | 1,455.00 |